Regenerative Medicine Market Size, Share to Amass Significant Gains During 2020-2025 – Industry News

The MarketWatch News Department was not involved in the creation of this content.

Dec 01, 2020 (Market Insight Reports) —
Selbyville, Delaware. The report Regenerative Medicine Market Size and Analysis maintains enhanced dynamics and is overshadowed by a top player across the globe. The research report provides Regenerative Medicine Market Growth and information corresponding to market segments such as geographies, product type, application, and end-use industry. Experts use the most recent Regenerative Medicine Market research techniques and tools to assemble widespread and precise marketing research reports. A detailed outline about Regenerative Medicine market size and share were combined in this report which gives a comprehensive analysis of different verticals of businesses.

The prevalence of diseases Alzheimera??s, diabetes and other chronic disorders is higher among the aging population across the globe. The incidence of diseases is getting increased day by day among the population. According to the Alzheimera??s Association, it is the 6th leading cause in the United States in 2020 and around 5 million individuals are living with Alzheimera??s. The use of regenerative medicine is getting popular and offers a complete cure from the disease. According to research report a??Global Regenerative Medicine Market Analysis, 2020a??, the Global Regenerative Medicine market is anticipated to grow at a CAGR of around 21.5% during 2020-25.

Request a sample Report of Regenerative Medicine Market [email protected] https://www.marketstudyreport.com/request-a-sample/2767182/?utm_source=marketwatch.com&utm_medium=ADS

Global Regenerative Medicine Market Analysis, 2020 research report depicts a deep dive market analysis of statistics of Global Regenerative Medicine market which consists of regional and country-wise market size, forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.

Pharmaceutical Remains a Dominant Sector

The pharmaceutical sector witnessed immense growth opportunities as more and more companies are indulging in research and studies for regenerative medicine in 2019. Vertex Pharmaceuticals Incorporated in 2018 got approval by FDA for launching their third medicine SYMDEKO for cystic fibrosis (CF) which is a genetic disorder affects liver, kidneys, pancreas, intestine, and lungs. These developments are propelling the growth of regenerative medicine and are expected to witness bolstering demand through 2025 as revealed by the research report a??Global Regenerative Medicine Market Analysis, 2020a??.

Musculoskeletal Disorders is Gaining Pace Across the Globe

The rising occurrence of arthritis and orthopedic diseases among the aging population as well as in the young population. Therefore, musculoskeletal disorders grabbed the largest market share in 2019. Moreover, diseases such as diabetes are also common in the Asian subcontinent. Moreover, around 34.2 million people of all ages or 10.5% of the US population had diabetes in 2018. Approximately, 34.1 million adults aged 18 years or older or 13.0% of all US adults had diabetes, according to US National Diabetes Statistics.

According to the key players with a considerable market share in the Global Regenerative Medicine market include Novartis AG, Vericel, Stryker, Spark Therapeutics, Wright Medical, Pfizer, Abbott, Astra Zenca Ltd., Astellas Pharma Inc., Osiris Therapeutics, Mimedx Group, Organogenesis Inc., Athersys, Inc, Acelity Holdings, Inc, etc.

Key Questions

Read more

Galacto-oligosaccharide Market | Europe to Present Significant Growth Opportunities Through 2024

The global galacto-oligosaccharide market is expected to grow by USD 486.79 million as per Technavio’s market research report. The analysis of the impact of COVID-19 on the market reveals a market slowdown in the first half of 2020,. However, the effect will gradually lessen in the coming quarters. In addition, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 10%. . Request Free Sample Report on COVID-19 Impacts

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201020005537/en/

Technavio has announced its latest market research report titled Global Galacto-oligosaccharide Market 2020-2024 (Graphic: Business Wire)

Read the 120-page report with TOC on “Galacto-oligosaccharide Market Analysis Report by Product (Syrup and Powder), Geography (Europe, North America, Asia, and ROW), and the Segment Forecasts, 2020-2024”. https://www.technavio.com/report/galacto-oligosaccharide-market-size-industry-analysis

The market is driven by the health benefits of galacto-oligosaccharides. In addition, the use of nutraceuticals and prebiotics in treating chronic diseases is anticipated to boost the growth of the galacto-oligosaccharide market.

Galacto-oligosaccharides are prebiotics and non-digestible food ingredients. They stimulate the activity of gut bacteria, which improves immunity, enhance the absorption of essential nutrients, and produce powerful antioxidant H2 gas. Galacto-oligosaccharides also inhibit the binding or survival of opportunistic microorganisms, such as Escherichia coli, Salmonella Typhimurium, and Clostridia. They can also influence the immune system by producing antimicrobial substances and inhibit the growth of pathogenic bacteria. Many such health benefits are fueling the growth of the global galacto-oligosaccharide market.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Galacto-oligosaccharide Companies:

Clasado Biosciences

Clasado Biosciences operates its business through a unified segment. The company offers Bimuno, which is a daily fiber supplement containing galacto-oligosaccharides, which feeds and stimulates the growth of good bacteria in the gut.

Fonterra Co operative Group Ltd.

Fonterra Co operative Group Ltd. operates its business through segments such as Ingredients, Consumer and foodservice, and China Farms. The company offers NZMP SureStart GOS, which is a prebiotic supplement added to infant formula products to make them closer to the composition of breast milk for mothers who cannot or choose not to breastfeed.

Ingredion Inc.

Ingredion Inc. operates its business through segments such as North America, South America, Asia Pacific, and EMEA. The company offers BIOLIGO GL 5700 IMF. It is a soluble dietary fiber made from lactose in the form of a syrup that contains 57% galacto-oligosaccharide.

Lactose (India) Ltd.

Lactose (India) Ltd. operates its business through a unified segment. The company offers galacto-oligosaccharide produced through the enzymatic conversion of lactose and is available in the powder form.

New Francisco (Yunfu City) Biotechnology Corp. Ltd.

New Francisco (Yunfu City) Biotechnology Corp. Ltd. operates its business through a unified segment. The company offers products such as GOS-270-P, GOS-700-P, and GOS-800-P.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Galacto-oligosaccharide Market Product Outlook (Revenue,

Read more